D. Taverner

511 total citations
32 papers, 330 citations indexed

About

D. Taverner is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Taverner has authored 32 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Taverner's work include Allergic Rhinitis and Sensitization (7 papers), Olfactory and Sensory Function Studies (6 papers) and Respiratory and Cough-Related Research (5 papers). D. Taverner is often cited by papers focused on Allergic Rhinitis and Sensitization (7 papers), Olfactory and Sensory Function Studies (6 papers) and Respiratory and Cough-Related Research (5 papers). D. Taverner collaborates with scholars based in Australia and United Kingdom. D. Taverner's co-authors include Jenny Latte, Sepehr Shakib, H. Thurston, J. D. Swales, R. F. Bing, Christopher R. Blagg, G.M. Bell, A L Muir, David J. Harrison and Simon Capewell and has published in prestigious journals such as Neurology, Cochrane Database of Systematic Reviews and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

D. Taverner

31 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Taverner Australia	11	109	108	82	66	59	32	330
Ploumis Pasadakis Greece	11	41 0.4×	29 0.3×	81 1.0×	5 0.1×	56 0.9×	27	428
Alan J. Wood United Kingdom	12	74 0.7×	42 0.4×	143 1.7×	14 0.2×	84 1.4×	21	384
Hylan A. Bickerman United States	16	461 4.2×	179 1.7×	59 0.7×	9 0.1×	23 0.4×	26	619
Scott Phillips United States	4	191 1.8×	33 0.3×	121 1.5×	22 0.3×	3 0.1×	5	674
Thomas Wegener Sweden	10	266 2.4×	301 2.8×	30 0.4×	22 0.3×	25 0.4×	23	475
Paul K. Hanashiro United States	9	80 0.7×	45 0.4×	65 0.8×	53 0.8×	100 1.7×	19	417
B Chernow United States	7	77 0.7×	45 0.4×	92 1.1×	8 0.1×	74 1.3×	11	318
Kenneth L. Haspel United States	6	88 0.8×	43 0.4×	118 1.4×	9 0.1×	72 1.2×	7	313
S. Lal United Kingdom	10	167 1.5×	143 1.3×	20 0.2×	23 0.3×	40 0.7×	19	314
T. M. Craft United Kingdom	8	101 0.9×	47 0.4×	43 0.5×	31 0.5×	98 1.7×	18	312

Countries citing papers authored by D. Taverner

Since Specialization

Citations

This map shows the geographic impact of D. Taverner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Taverner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Taverner more than expected).

Fields of papers citing papers by D. Taverner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Taverner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Taverner. The network helps show where D. Taverner may publish in the future.

Co-authorship network of co-authors of D. Taverner

This figure shows the co-authorship network connecting the top 25 collaborators of D. Taverner. A scholar is included among the top collaborators of D. Taverner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Taverner. D. Taverner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taverner, D., et al.. (2007). Nasal decongestants for the common cold. Cochrane Database of Systematic Reviews. CD001953–CD001953. 69 indexed citations

Latte, Jenny & D. Taverner. (2007). Clinical Trial of 3 Days of Treatment with Oral Pseudoephedrine for the Common Cold in the Southern Hemisphere. American Journal of Rhinology. 21(4). 452–455. 10 indexed citations

Tonkin, Anne, D. Taverner, Jenny Latte, & Christopher J Doecke. (2006). The Effect of an Interactive Tutorial on the Prescribing Performance of Senior Medical Students. Medical Education Online. 11(1). 4588–4588. 7 indexed citations

Latte, Jenny & D. Taverner. (2005). Opening the Nasal Valve with External Dilators Reduces Congestive Symptoms in Normal Subjects. American Journal of Rhinology. 19(2). 215–219. 17 indexed citations

Taverner, D., et al.. (2004). Nasal decongestants for the common cold. Cochrane Database of Systematic Reviews. CD001953–CD001953. 13 indexed citations

Latte, Jenny, D. Taverner, Peter Slobodian, & Sepehr Shakib. (2004). A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL OF PSEUDOEPHEDRINE IN CORYZA. Clinical and Experimental Pharmacology and Physiology. 31(7). 429–432. 9 indexed citations

Taverner, D., et al.. (1999). The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clinical Otolaryngology. 24(1). 47–51. 31 indexed citations

Taverner, D., et al.. (1999). CROSS‐OVER COMPARISON OF NIFEDIPINE OROS^® AND FELODIPINE EXTENDED RELEASE WITH BLIND 24 H AMBULATORY BLOOD PRESSURE ASSESSMENTS. Clinical and Experimental Pharmacology and Physiology. 26(11). 909–913.

Shakib, Sepehr, et al.. (1999). The nasal airways response in normal subjects to oxymetazoline spray: randomized double‐blind placebo‐controlled trial. British Journal of Clinical Pharmacology. 48(1). 53–56. 18 indexed citations

10.

Taverner, D., et al.. (1999). Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adults. European Journal of Clinical Pharmacology. 55(7). 509–513. 12 indexed citations

11.

Taverner, D., et al.. (1996). REPRODUCIBILITY OF CONVENTIONAL AND POWER SPECTRAL MEASUREMENTS OF CARDIOVASCULAR SYMPATHETIC ACTIVATION IN NORMAL SUBJECTS. Clinical and Experimental Pharmacology and Physiology. 23(9). 804–806. 6 indexed citations

12.

Taverner, D., et al.. (1991). Effects of Exercise on Renal Function in Patients with Moderate Impairment of Renal Function Compared to Normal Men. The Nephron journals/Nephron journals. 57(3). 288–292. 17 indexed citations

13.

Capewell, Simon, D. Taverner, W. J. Hannan, & A L Muir. (1989). Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.. BMJ. 299(6705). 942–945. 14 indexed citations

14.

Taverner, D., David J. Harrison, & G.M. Bell. (1988). Acute Renal Failure Due to Interstitial Nephritis Induced by ‘Glue-Sniffing’ with Subsequent Recovery. Scottish Medical Journal. 33(2). 246–247. 11 indexed citations

15.

Swales, J. D., R. F. Bing, Ginny Russell, D. Taverner, & H. Thurston. (1986). Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.. PubMed. 4(4). S43–6. 4 indexed citations

16.

Swales, J. D., et al.. (1984). Effect of Unclipping on Pressor Responses in Rats with Renovascular Hypertension. Clinical Science. 66(4). 473–480. 4 indexed citations

17.

Carr‐Locke, David L., D. Taverner, & A C Wicks. (1984). Cimetidine therapy does not prevent rebleeding from peptic ulceration. Postgraduate Medical Journal. 60(704). 400–403. 3 indexed citations

18.

Taverner, D., et al.. (1983). Chemical renal medullectomy: effect on blood pressure in normal rats.. PubMed. 1(2). 43–5. 3 indexed citations

19.

Feehally, John, D. Taverner, A C Burden, & John Walls. (1983). Predictors of renal function in diabetic and non-diabetic renal disease. Clinica Chimica Acta. 133(2). 169–175. 2 indexed citations

20.

Blagg, Christopher R., et al.. (1968). Nerve Conduction Velocity in Relationship to the Severity of Renal Disease. The Nephron journals/Nephron journals. 5(4). 290–299. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact